Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions
Abstract Urologic pathology is rapidly evolving to adopt growing knowledge of molecular pathways involved in genitourinary neoplasm. Many prognostic and predictive biomarkers are under active research and some of them have been incorporated in clinical practice. In this review, we will discuss recent developments of Molecular Pathology of prostate, bladder and testicular tumors with special emphasis on prognostic and predictive biomarkers.
Authors
- Stephania Martins Bezerra (ORCID: https://orcid.org/0000-0002-5996-7342)
- Luiza Fadul Gallas
- Andres Martin Acosta (ORCID: https://orcid.org/0000-0001-8817-6331)
- José Maurício Mota (ORCID: https://orcid.org/0000-0001-9510-6956)
- João Lobo (ORCID: https://orcid.org/0000-0001-6829-1391)
- Daniel Abensur Athanazio (ORCID: https://orcid.org/0000-0002-5280-8517)
- Mariana Andozia Morini
- María Belén Molina Froján
Institutions
- Universidade Federal da Bahia (BR)
- Universidade de São Paulo (BR)
- Universidade do Porto (PT)
- AC Camargo Hospital (BR)
- Southwest Bahia State University (BR)
- Complexo Hospitalar Universitário Professor Edgard Santos (BR)
- Instituto do Câncer do Estado de São Paulo (BR)
- Hospital Fernández (AR)
- D’Or Institute for Research and Education (BR)
- Instituto Português de Oncologia Francisco Gentil (PT)
- IPO Porto (PT)
- Faculdade de Medicina do ABC (BR)
- Hospital São Paulo (BR)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Surgical and Experimental Pathology
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s42047-024-00158-0
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00